Table 2 Clinical and pathological characteristics of the study population
Study population | (%) for cases with observed data |
|---|---|
Age at diagnosis (year), median ± standard error | 59.29 ± 9.59 |
MI | |
No | 51 (10.41%) |
Yes | 439 (89.59%) |
Year of diagnosis | |
2000–2007 | 21 (4.29%) |
2008–2009 | 26 (5.31%) |
2010–2011 | 40 (8.16%) |
2012–2013 | 61 (12.45%) |
2014–2015 | 151 (30.82%) |
2016–2017 | 171 (34.90%) |
2018–2019 | 20 (4.08%) |
Evaluating method of MI | |
CT | 50 (10.20%) |
MRI | 186 (37.96%) |
IGE | 341 (69.59%) |
IFS | 115 (23.47%) |
Pathological subtype | |
Serous carcinoma | 272 (55.51%) |
Clear cell carcinoma | 128 (26.12%) |
Undifferentiated carcinoma | 29 (5.92%) |
Carcinosarcoma | 37 (7.55%) |
Mixed | 24 (4.90%) |
Grade | |
Grade 1 | 128 (26.12%) |
Grade 2 | 102 (20.82%) |
Grade 3 | 168 (34.29%) |
Undifferentiation | 92 (18.78%) |